O'Shaughnessy Asset Management’s Ovid Therapeutics OVID Stock Holding History

O'Shaughnessy Asset Management’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-42,028	Closed	-$132K	–	1335
2022 Q1	$132K	Buy	+42,028	New	+$132K	﹤0.01%	1111
2021 Q4	–	Sell	-1,913	Closed	-$6K	–	2098
2021 Q3	$6K	Buy	1,913 +185	+11%	+$675	﹤0.01%	2286
2021 Q2	$7K	Hold	1,728	–	–	﹤0.01%	2076
2021 Q1	$7K	Hold	1,728	–	–	﹤0.01%	1862
2020 Q4	$4K	Hold	1,728	–	–	﹤0.01%	1730
2020 Q3	$10K	Hold	1,728	–	–	﹤0.01%	1361
2020 Q2	$13K	Buy	+1,728	New	+$8.08K	﹤0.01%	1213
2020 Q1	–	Sell	-4,966	Closed	-$21K	–	1663
2019 Q4	$21K	Buy	+4,966	New	+$15.7K	﹤0.01%	1140

Other funds holding OVID

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

O'Shaughnessy Asset Management's OVID Position: Q2 2022 in Review

O'Shaughnessy Asset Management sold out of Ovid Therapeutics (OVID) in Q2 2022, closing a stake of 42,028 shares — an estimated $132K sold.

O'Shaughnessy Asset Management first reported a position in OVID in Q4 2019 and held it in 8 quarters. The position peaked at $132K in Q1 2022. 55 funds tracked by Wall St. Rank hold OVID as of Q2 2022.

O'Shaughnessy Asset Management reported no remaining Ovid Therapeutics position as of Q2 2022 after selling out during the quarter.
O'Shaughnessy Asset Management sold 42,028 Ovid Therapeutics shares in Q2 2022, an estimated $132K.
O'Shaughnessy Asset Management first reported a position in Ovid Therapeutics in Q4 2019 and held it in 8 quarters.
O'Shaughnessy Asset Management's Ovid Therapeutics position peaked at $132K in Q1 2022.
55 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2022.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2022, filed 11 Aug 2022.